IO Biotech, Inc.

NASDAQ:IOBT

1.5 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 000001.11000000000000000
Cost of Revenue 00.21900.2140.2110.2010.1940.1870.1740.1900000000000
Gross Profit 000-0.214-0.2110.909-0.194-0.187-0.174-0.1900000000000
Gross Profit Ratio 000000.819000000000000000
Reseach & Development Expenses 16.37521.14720.17815.84814.31121.7717.65516.50411.914.43310.02212.22610.30616.444.1286.7352.8482.212.7771.7381.738
General & Administrative Expenses 6.2095.7966.3265.6855.8866.4135.8295.3486.0245.9555.8435.9356.7044.9552.9142.2480.9650.3290.6540.350.35
Selling & Marketing Expenses 00000-0.201000000000000000
SG&A 6.2095.7966.3265.6855.8866.2125.8295.3486.0245.9555.8435.9356.7044.9552.9142.2480.9650.3290.6540.350.35
Other Expenses 00000000000000.2952.63-29.460-0.028-0.04100
Operating Expenses 22.58426.94326.50421.53320.19727.98223.48421.85217.92420.38815.86518.16117.0121.3957.0428.9833.8132.5393.4312.9962.996
Operating Income -22.584-26.943-26.504-21.533-20.197-28.183-23.484-21.852-17.924-20.388-15.865-18.161-17.01-21.395-7.042-8.983-3.813-2.539-3.431-2.088-2.088
Operating Income Ratio 00000-25.39000000000000000
Total Other Income Expenses Net 0.309-3.9452.6981.2211.1552.3541.3661.2061.2861.3050.292-0.23-0.1280.1542.58-29.3760.065-0.015-0.057-0.913-0.913
Income Before Tax -22.275-30.888-23.806-20.312-19.042-25.829-22.118-20.646-16.638-19.085-15.573-18.391-17.138-21.241-4.462-38.359-3.748-2.554-3.488-3-3
Income Before Tax Ratio 00000-23.269000000000000000
Income Tax Expense 0.1460.4450.2090.3740.4150.353-0.4390.5320.4060.9870.1150.1040.0660.0680.0670.071-3.7410.0110.007-0.913-0.913
Net Income -22.421-31.333-24.015-20.686-19.457-26.182-21.679-21.178-17.044-20.072-15.688-18.495-17.204-21.309-4.462-38.359-3.748-2.554-3.488-3.511-3.511
Net Income Ratio 00000-23.587000000000000000
EPS -0.34-0.48-0.36-0.31-0.3-0.4-0.43-0.73-0.59-0.7-0.54-0.64-0.6-0.83-0.17-3.32-0.32-0.22-0.3-19.83-19.83
EPS Diluted -0.34-0.48-0.36-0.31-0.3-0.4-0.43-0.73-0.59-0.7-0.54-0.64-0.6-0.83-0.17-3.32-0.32-0.22-0.3-19.81-19.81
EBITDA -22.584-26.724-26.299-21.319-19.986-25.628-21.924-21.665-17.75-18.894-15.376-18.289-16.795-21.09-4.395-38.28700000
EBITDA Ratio 00000-23.088000000000000000